Related Experiment Video
Updated: Jul 13, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
[Fifteen practical questions concerning gestational diabetes]
J-C Clay1, P Deruelle, C Fischer
1Service de gynécologie-obstétrique, hôpital Jeanne-de-Flandre, université Lille-II, CHRU de Lille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France. jcclay@hotmail.fr
Gynecologie, Obstetrique & Fertilite
|August 19, 2007
Summary
Screening and managing gestational diabetes is crucial for improving pregnancy outcomes, with treatments like diet and insulin significantly reducing complications. However, consensus on optimal screening and diagnostic strategies is still lacking.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
Context:
- Gestational diabetes mellitus (GDM) prevalence varies significantly by ethnicity, ranging from 1% to 14%.
- Current diagnostic methods include the Sullivan 50g (1-hour) and 100g (3-hour) glucose tolerance tests, and the WHO 75g (2-hour) test.
- Screening approaches differ, with some countries employing systematic screening and others focusing on risk factors.
Purpose:
- To review current literature and provide clarification on the screening and management of gestational diabetes.
- To highlight the importance of GDM management in improving perinatal outcomes.
- To discuss the ongoing debate regarding screening strategies and the role of oral treatments like glyburide.
Summary:
- Gestational diabetes management, including dietary advice and insulin, significantly reduces perinatal complications by 4-fold.
- The ACHOIS study provides evidence for the benefits of GDM treatment.
- The optimal strategy for screening and diagnosis of GDM remains undefined, with variations in practice globally.
Impact:
- Effective management of gestational diabetes leads to a substantial decrease in perinatal complications.
- Standardizing screening and diagnostic protocols can improve maternal and fetal health outcomes.
- Further research is needed to define the role of oral hypoglycemic agents in GDM management.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...